Lesions with increased fragility and permeability of capillaries (diabetic retinopathy and nephropathy) and other microangiopathy associated with various cardio and metabolic diseases.
Venous insufficiency of varying severity and its consequences (predvarikoznoe condition with signs of tissue edema, pain, paresthesias , congestive dermatosis, winstrol cycle superficial phlebitis, varicose veins, trophic ulcers).
Hypersensitivity to the drug, peptic ulcer and 12 duodenal ulcer (in the acute stage), bleeding from the gastrointestinal tract, liver and kidney disease, hemorrhage caused by anticoagulant; pregnancy (I trimester), children’s age (13 years).
Dosing and Administration
The inside is not liquid, during a meal.
Assign to 500 mg 3 times daily for 2-3 weeks, then reduce the dose to 500 mg 1 time per day. In the treatment of retinopathy and microangiopathy 500 mg administered three times a day for 4-6 months and then reduced to a daily dose of 500 mg 1 time per day.
Disorders of the gastrointestinal tract (nausea, vomiting, diarrhea, gastralgia), allergic dermatosis, increased activity of “liver” transaminases febrile reactions, headache, dizziness.
No cases of overdose were reported.
Interaction with other drugs
increases the effects of anticoagulants, heparin, corticosteroids, hypoglycemic effect of sulfonylureas. Increases antiplatelet activity of ticlopidine. Do not combine winstrol cycle with drugs Li + and methotrexate.
The drug can be administered prophylactically.
The dose should be reduced in the case of severe renal failure requiring dialysis.
Capsules 500 mg. 10 capsules in blister PVC / A1. 3 blisters with instructions for use in paper cartons.
At temperatures between 15 and 25 ° C in a dry place.
Keep out of the reach of children.
5 years. Do not use after winstrol cycle the expiration date printed on the package.